Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology · Aortic Stenosis

How Do Rheumatic and Calcific Aortic Valve Stenosis Differ?

At a Glance

Rheumatic aortic stenosis develops from scarring after rheumatic fever and may affect other valves, while calcific aortic stenosis usually comes from age-related calcium buildup. These differences shape imaging, valve replacement choices, and the need for antibiotic prevention.

Rheumatic aortic stenosis and calcific aortic stenosis both cause a narrowing of the heart’s aortic valve, but they develop for different reasons and affect the valve’s structure differently. Calcific aortic stenosis is an age-related condition that occurs over time as calcium deposits build up on the valve [1] [2]. In contrast, rheumatic aortic stenosis is a consequence of rheumatic fever—an abnormal immune response to a previous bacterial infection (like group A strep throat) that scars the valve tissue [3]. Because the underlying causes, resulting structural changes, and the likelihood of other valves being involved differ, doctors evaluate and treat these two conditions with different considerations in mind.

Understanding the Causes

Calcific aortic valve disease is an age-related process [2]. As we age, the valve leaflets (the flaps that open and close to control blood flow) can undergo thickening, scarring (fibrosis), and gradual mineralization (calcium buildup) [1] [2]. This is the most common type of aortic stenosis in adults. While no proven medication reverses the valve obstruction, managing blood pressure, cholesterol, and other cardiovascular conditions remains important for your overall heart health.

Rheumatic aortic stenosis is a long-term complication of rheumatic heart disease, which begins with an episode of rheumatic fever [3]. The initial group A strep infection triggers an abnormal immune response that causes inflammation and scarring in the heart tissues [3]. While this inflammatory response often begins in childhood or young adulthood, it can take decades for the valve narrowing to become severe enough to cause symptoms [4].

(Note: Other conditions can also cause aortic stenosis, such as a congenital bicuspid valve or prior radiation therapy, but calcific and rheumatic diseases are the primary focus here).

How the Valve Anatomy Differs

The physical changes to the valve leaflets often show different patterns on an echocardiogram (ultrasound of the heart) depending on the cause, though there can be overlap:

  • Calcific Stenosis: The primary issue is heavy calcium buildup, usually starting at the base (or hinge) of the leaflets and extending outward [2] [1]. This rigid calcification restricts the leaflets from opening fully.
  • Rheumatic Stenosis: The hallmark of rheumatic disease is commissural fusion [4]. This means the commissures (the edges where the leaflets are supposed to separate) become glued or scarred together [4]. The leaflets become thickened and irregular, but they often have relatively less calcium buildup compared to the degenerative type [4] [5].

It is important to note that these features can mix over time. Rheumatic valves can become heavily calcified as patients age, and a diagnosis is made by combining imaging findings with your medical history and a specialist’s assessment [4].

Involvement of Other Heart Valves

A crucial difference in evaluating these conditions is whether other heart valves are affected. Calcific aortic stenosis often exists as an isolated issue at the aortic valve.

Rheumatic heart disease, however, frequently affects more than one valve. The mitral valve is the most frequently affected valve in rheumatic disease, making isolated rheumatic aortic stenosis relatively uncommon [4] [6]. If you have rheumatic disease, your doctor will closely evaluate your other valves for narrowing (stenosis) or leaking backward (regurgitation) because the presence of multiple diseased valves significantly changes the treatment approach [7] [8].

Treatment Options and Considerations

Learning you may need valve treatment can be frightening. It is important to know that a diagnosis alone does not mean you need immediate surgery. Intervention is based on confirmed severity, your symptoms, how well your heart is pumping, your age, surgical risk, and your specific anatomy.

When treatment is needed, the structural differences between rheumatic and calcific disease influence how the valve is replaced.

  • Transcatheter Aortic Valve Replacement (TAVR): This minimally invasive procedure involves placing a replacement valve inside the diseased one. It often relies on a rigid, calcified structure to help the new valve anchor securely [9]. Because rheumatic valves often have less calcium and different anatomical shapes, TAVR can be technically more challenging, with higher risks of the new valve slipping out of place or leaking [10] [9]. While TAVR is a standard option for many patients with calcific disease, it is carefully evaluated by a multidisciplinary Heart Team for patients with rheumatic stenosis, often reserved for those who are older or at high surgical risk [6] [11].
  • Surgical Aortic Valve Replacement (SAVR): Open-heart surgery remains the standard of care for severe rheumatic aortic stenosis, especially for younger patients or those with complex anatomy [11] [6]. Surgery allows the team to completely remove the scarred tissue and sew in a new valve. Importantly, it also allows the surgeon to repair or replace the mitral valve at the same time if multiple valves are affected [12].

Preventing Recurrent Rheumatic Fever

If you have rheumatic aortic stenosis, a critical part of your care involves preventing further damage. Patients with rheumatic heart disease are often prescribed scheduled, long-term antibiotics (known as secondary prophylaxis) [13] [14]. This usually involves injections of benzathine penicillin every 3 to 4 weeks, or an appropriate oral alternative if you have allergies [13] [14].

This treatment is designed to prevent repeat episodes of rheumatic fever, which could cause additional inflammatory damage [15]. It does not reverse existing valve damage. The duration of this treatment depends on your age, the severity of your valve disease, and the time since your last rheumatic fever episode [16] [17]. You should never start, stop, or change your antibiotic regimen without consulting your clinician.

When to Seek Urgent Medical Care

Do not wait for a routine appointment if your condition changes. Seek urgent or emergency medical help if you experience:

  • New or worsening chest pain
  • Fainting or feeling like you might pass out
  • Severe shortness of breath, especially when resting
  • A sudden, significant decline in your ability to exercise or perform daily activities

Summary Comparison

Feature Calcific Aortic Stenosis Rheumatic Aortic Stenosis
Typical Cause Age-related mineralization and wear [2] Abnormal immune response after a strep infection [3]
Valve Anatomy Heavy calcium buildup at leaflet bases [1] Commissural fusion (edges scarred together) [4]
Other Valves Often isolated to the aortic valve Frequently involves the mitral valve [6]
Prevention Manage overall heart health (blood pressure, cholesterol) Long-term scheduled antibiotics to prevent rheumatic fever [15]
Treatment Considerations Both TAVR and SAVR are standard options, depending on risk SAVR is standard, particularly if the mitral valve is involved; TAVR for selected patients [11] [6]

Common questions in this guide

What is the main difference between rheumatic and calcific aortic stenosis?
Rheumatic aortic stenosis develops from inflammation and scarring after rheumatic fever, often causing the valve edges to fuse. Calcific aortic stenosis usually develops with age as calcium builds up and stiffens the valve leaflets. The two types can overlap, so doctors consider both imaging and medical history.
How can an echocardiogram help distinguish the two types of aortic stenosis?
Calcific stenosis often shows heavy calcium near the bases or hinges of the valve leaflets. Rheumatic stenosis more often shows scarring and fusion where the leaflet edges meet, with less calcium early on. Because the findings can overlap, a specialist also considers your history of rheumatic fever and whether other valves are affected.
Can rheumatic aortic stenosis affect other heart valves?
Yes. Rheumatic heart disease commonly affects the mitral valve and may involve more than one valve, causing narrowing or leakage. Finding additional valve disease can change the timing and type of treatment.
Is TAVR an option for people with rheumatic aortic stenosis?
TAVR may be considered for selected people with rheumatic aortic stenosis, especially those who are older or have a high risk from surgery. Rheumatic valves may have less calcium or an unusual shape, which can make it harder for a replacement valve to stay secure. Surgical valve replacement is generally the standard option for severe rheumatic disease, particularly in younger people or those with complex valve anatomy.
Do people with rheumatic aortic stenosis need long-term antibiotics?
Many people with rheumatic heart disease receive scheduled antibiotics to prevent repeat rheumatic fever and further valve damage. This prevention does not repair valve damage that already exists, and the medication, schedule, and duration depend on your individual history. Do not start, stop, or change antibiotics without speaking with your clinician.
What symptoms of aortic stenosis need urgent medical attention?
Seek urgent or emergency care for new or worsening chest pain, fainting or near-fainting, severe shortness of breath at rest, or a sudden major decline in your ability to exercise or perform daily activities. These symptoms can signal a serious change in heart function.

Get notified when new evidence is published on aortic valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.

    Gomez-Stallons MV, Tretter JT, Hassel K, et al.

    Heart (British Cardiac Society) 2019; (105(21)):1616-1621 doi:10.1136/heartjnl-2019-314879.

    PMID: 31171628
  2. 2

    Calcific aortic valve disease: mechanisms, prevention and treatment.

    Moncla LM, Briend M, Bossé Y, Mathieu P

    Nature reviews. Cardiology 2023; (20(8)):546-559 doi:10.1038/s41569-023-00845-7.

    PMID: 36829083
  3. 3

    A Rare Case of Congestive Heart Failure due to Isolated Aortic Valve Disease in a Middle-Aged Man Secondary to Rheumatic Fever.

    Panduranga VT, Gorantla A, Ahmed A, et al.

    Journal of medical cases 2023; (14(5)):149-154 doi:10.14740/jmc4090.

    PMID: 37303970
  4. 4

    Transcatheter aortic valve replacement in patients with degenerative calcified rheumatic aortic stenosis: A 10-patient case series.

    Saji M, Highchi R, Iguchi N, et al.

    International journal of cardiology 2019; (280()):38-42 doi:10.1016/j.ijcard.2018.11.090.

    PMID: 30503242
  5. 5

    Transcatheter aortic valve implantation in rheumatic aortic stenosis with a functioning mitral prosthesis.

    Ichise T, Mabuchi T, Uehara M, et al.

    Journal of cardiology cases 2021; (24(2)):84-88 doi:10.1016/j.jccase.2021.02.002.

    PMID: 34354784
  6. 6

    Transcatheter aortic valve implantation in patients with rheumatic aortic stenosis.

    Okuno T, Tomii D, Buffle E, et al.

    Heart (British Cardiac Society) 2022; (108(15)):1225-1233 doi:10.1136/heartjnl-2021-320531.

    PMID: 35351823
  7. 7

    Degenerative Mitral Stenosis: From Pathophysiology to Challenging Interventional Treatment.

    Banovic M, DaCosta M

    Current problems in cardiology 2019; (44(1)):10-35 doi:10.1016/j.cpcardiol.2018.03.004.

    PMID: 29731112
  8. 8

    Surgical treatment for degenerative mitral stenosis associated with aortic valve stenosis: A case report.

    Nakai T, Okada Y, Adachi K, Muro T

    Journal of cardiology cases 2024; (29(3)):120-123 doi:10.1016/j.jccase.2023.11.004.

    PMID: 38481641
  9. 9

    Transcatheter heart valve interventions for patients with rheumatic heart disease.

    Weich H, Herbst P, Smit F, Doubell A

    Frontiers in cardiovascular medicine 2023; (10()):1234165 doi:10.3389/fcvm.2023.1234165.

    PMID: 37771665
  10. 10

    Clinical efficacy of transcatheter aortic valve replacement in patients with rheumatic aortic stenosis.

    Wang Y, Wang M, Liu T, et al.

    BMC cardiovascular disorders 2026; (26(1)).

    PMID: 41709159
  11. 11

    Transcatheter Aortic Valve Replacement in Rheumatic Aortic Stenosis: A Comprehensive Review.

    Okor I, Bob-Manuel T, Garikapati K, et al.

    Current problems in cardiology 2021; (46(12)):100843 doi:10.1016/j.cpcardiol.2021.100843.

    PMID: 33994024
  12. 12

    Concurrent Transcatheter Aortic Valve Implantation and Percutaneous Transvenous Mitral Commissurotomy for Totally Percutaneous Treatment of Combined Severe Rheumatic Aortic and Mitral Stenosis.

    Bilge M, Alsancak Y, Ali S, Yasar AS

    The Journal of heart valve disease 2015; (24(3)):286-9.

    PMID: 26901896
  13. 13

    Therapeutics for rheumatic fever and rheumatic heart disease.

    Ralph AP, Currie BJ

    Australian prescriber 2022; (45(4)):104-112 doi:10.18773/austprescr.2022.034.

    PMID: 36110174
  14. 14

    Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.

    Wyber R, Boyd BJ, Colquhoun S, et al.

    Drug delivery and translational research 2016; (6(5)):572-8 doi:10.1007/s13346-016-0313-z.

    PMID: 27465618
  15. 15

    Long-term antibiotic prophylaxis for prevention of rheumatic fever recurrence and progression to rheumatic heart disease.

    Bray JJ, Thompson S, Seitler S, et al.

    The Cochrane database of systematic reviews 2024; (9()):CD015779 doi:10.1002/14651858.CD015779.

    PMID: 39312290
  16. 16

    Acute rheumatic fever and rheumatic heart disease among children--American Samoa, 2011-2012.

    Beaudoin A, Edison L, Introcaso CE, et al.

    MMWR. Morbidity and mortality weekly report 2015; (64(20)):555-8.

    PMID: 26020139
  17. 17

    Rheumatic Heart Disease Prophylaxis in Older Patients: A Register-Based Audit of Adherence to Guidelines.

    Holland JV, Hardie K, de Dassel J, Ralph AP

    Open forum infectious diseases 2018; (5(6)):ofy125 doi:10.1093/ofid/ofy125.

    PMID: 29942824

This page is for informational purposes only and does not constitute medical advice. Your cardiologist or Heart Team should interpret your echocardiogram and recommend treatment for your specific situation.